14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.420 $1.05 Friday, 3rd May 2024 RNAZ stock ended at $0.82. This is 15.98% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 51.08% from a day low at $0.695 to a day high of $1.05.
90 days $0.420 $1.05
52 weeks $0.121 $7.74

Historical TransCode Therapeutics, Inc. prices

Date Open High Low Close Volume
May 03, 2024 $0.750 $1.05 $0.695 $0.82 5 867 190
May 02, 2024 $0.643 $0.787 $0.630 $0.707 1 857 467
May 01, 2024 $0.605 $0.639 $0.590 $0.630 407 271
Apr 30, 2024 $0.600 $0.620 $0.560 $0.607 478 804
Apr 29, 2024 $0.549 $0.629 $0.530 $0.587 1 114 705
Apr 26, 2024 $0.530 $0.576 $0.502 $0.550 692 659
Apr 25, 2024 $0.440 $0.538 $0.440 $0.525 1 228 831
Apr 24, 2024 $0.446 $0.460 $0.420 $0.440 90 131
Apr 23, 2024 $0.459 $0.469 $0.450 $0.460 98 964
Apr 22, 2024 $0.490 $0.490 $0.421 $0.459 277 375
Apr 19, 2024 $0.490 $0.503 $0.476 $0.485 112 580
Apr 18, 2024 $0.509 $0.520 $0.475 $0.502 269 530
Apr 17, 2024 $0.519 $0.540 $0.481 $0.502 277 266
Apr 16, 2024 $0.530 $0.530 $0.470 $0.505 420 597
Apr 15, 2024 $0.622 $0.659 $0.500 $0.536 3 527 726
Apr 12, 2024 $0.621 $0.640 $0.610 $0.621 113 933
Apr 11, 2024 $0.635 $0.652 $0.600 $0.639 114 828
Apr 10, 2024 $0.640 $0.669 $0.635 $0.641 71 608
Apr 09, 2024 $0.640 $0.660 $0.640 $0.640 82 824
Apr 08, 2024 $0.640 $0.660 $0.635 $0.655 60 501
Apr 05, 2024 $0.669 $0.670 $0.640 $0.640 80 907
Apr 04, 2024 $0.655 $0.685 $0.651 $0.680 54 840
Apr 03, 2024 $0.675 $0.685 $0.650 $0.650 169 275
Apr 02, 2024 $0.671 $0.696 $0.660 $0.682 233 141
Apr 01, 2024 $0.663 $0.708 $0.660 $0.692 162 863
Click to get the best stock tips daily for free!

About TransCode Therapeutics, Inc.

TransCode Therapeutics. TransCode Therapeutics, Inc., a biopharmaceutical company, engages in the development and commercialization of drugs and diagnostics for treating and identifying metastatic disease. Its lead therapeutic candidate, TTX-MC138, is a preclinical stage product for the treatment of metastatic cancer. The company's products in preclinical programs include TTX-siPDL1, an siRNA-based modulator of programmed death-ligand 1; TTX-siLIN28B, an siRNA-based inh... RNAZ Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT